NDC 22840-2618

Phoma betae

Phoma Betae

Phoma betae is a Intradermal; Percutaneous; Subcutaneous Solution in the Non-standardized Allergenic category. It is labeled and distributed by Greer Laboratories, Inc.. The primary component is Pleospora Betae.

Product ID22840-2618_77436178-2957-6a77-e053-2a91aa0a873e
NDC22840-2618
Product TypeNon-standardized Allergenic
Proprietary NamePhoma betae
Generic NamePhoma Betae
Dosage FormSolution
Route of AdministrationINTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS
Marketing Start Date1981-09-15
Marketing CategoryBLA / BLA
Application NumberBLA101833
Labeler NameGreer Laboratories, Inc.
Substance NamePLEOSPORA BETAE
Active Ingredient Strength0 g/mL
Pharm ClassesIncreased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [CS],Allergens [CS],Non-Standardized Fungal Allergenic Extract [EPC]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 22840-2618-1

5 mL in 1 VIAL, MULTI-DOSE (22840-2618-1)
Marketing Start Date1981-09-15
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 22840-2618-1 [22840261801]

Phoma betae SOLUTION
Marketing CategoryBLA
Application NumberBLA101833
Product TypeNON-STANDARDIZED ALLERGENIC
Marketing Start Date1981-09-15

Drug Details

Active Ingredients

IngredientStrength
PLEOSPORA BETAE.001 g/mL

Pharmacological Class

  • Increased Histamine Release [PE]
  • Cell-mediated Immunity [PE]
  • Increased IgG Production [PE]
  • Fungal Proteins [CS]
  • Allergens [CS]
  • Non-Standardized Fungal Allergenic Extract [EPC]

NDC Crossover Matching brand name "Phoma betae" or generic name "Phoma Betae"

NDCBrand NameGeneric Name
22840-2618Phoma betaePhoma betae
22840-2674Phoma betaePhoma betae
22840-5632Phoma betaePhoma betae
49643-116PhomaPhoma betae

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.